These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10921534)

  • 21. Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients.
    Furuya R; Kumagai H; Takahashi M; Sano K; Hishida A
    Blood Purif; 2005; 23(4):311-6. PubMed ID: 15980621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute changes in endothelin after hemodialysis in children.
    Noyan A; Anarat A; Anarat R; Noyan T
    Pediatr Nephrol; 1998 Feb; 12(2):153-6. PubMed ID: 9543379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma sodium setpoint: is it constant or changed by hemodialysis prescription?
    Thomson BK; Huang SH; Chan CT; House AA; Lindsay RM
    ASAIO J; 2013; 59(5):497-504. PubMed ID: 23896770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodialysis-induced hypoglycemia in diabetic patients.
    Jackson MA; Holland MR; Nicholas J; Lodwick R; Forster D; Macdonald IA
    Clin Nephrol; 2000 Jul; 54(1):30-4. PubMed ID: 10939754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodialysis blood access flow rates can be estimated accurately from on-line dialysate urea measurements and the knowledge of effective dialyzer urea clearance.
    Lindsay RM; Sternby J; Olde B; Persson R; Thatcher ME; Sargent K
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):960-4. PubMed ID: 17699313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal composition of the dialysate, with emphasis on its influence on blood pressure.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M
    Nephrol Dial Transplant; 2004 Apr; 19(4):785-96. PubMed ID: 15031331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities.
    Buchman AL; Moukarzel A; Jenden DJ; Roch M; Rice K; Ament ME
    Clin Nutr; 1993 Feb; 12(1):33-7. PubMed ID: 16843274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.
    Buturovic-Ponikvar J; Cerne S; Gubensek J; Ponikvar R
    Int J Artif Organs; 2008 May; 31(5):418-24. PubMed ID: 18609515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-bound solute removal during extended multipass versus standard hemodialysis.
    Eloot S; Van Biesen W; Axelsen M; Glorieux G; Pedersen RS; Heaf JG
    BMC Nephrol; 2015 Apr; 16():57. PubMed ID: 25896788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation.
    Buchman AL; Dubin MD; Moukarzel AA; Jenden DJ; Roch M; Rice KM; Gornbein J; Ament ME
    Hepatology; 1995 Nov; 22(5):1399-403. PubMed ID: 7590654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy.
    Zabaneh RI; Bhatt DM; Yu AW; Tiwari P; Lai CI; Leehey DJ; Ing TS
    Nephron; 1996; 72(4):696-8. PubMed ID: 8730447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
    Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
    Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
    Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
    Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effect of dialysate calcium concentration and intravenous vitamin D3 on the secretion of parathyroid hormone in hemodialysis patients.
    Saha H; Pietilä K; Mustonen J; Pasternack A; Mörsky P
    Clin Nephrol; 1992 Sep; 38(3):145-8. PubMed ID: 1395167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
    Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.